Le Lézard
Classified in: Science and technology

CCTV+: China's first lady Peng Liyuan visits opera house in Hong Kong


BEIJING, July 2, 2022 /CNW/ -- Peng Liyuan, wife of Chinese President Xi Jinping, on Thursday visited the Xiqu Center in Hong Kong's West Kowloon Cultural District, a venue for the art of Chinese traditional theater. 

She watched rehearsals of Cantonese opera performances and a Hong Kong orchestra at the opera house and spoke highly of the performances, calling the show a display of the charm of Chinese culture. 

During her visit, Peng also talked with young volunteers who were making traditional paper artworks. She encouraged Hong Kong's younger generation to have an in-depth understanding of fine traditional Chinese culture and inherit and promote the culture.

Peng together with Xi left Hong Kong Friday after a two-day trip there for a meeting celebrating the 25th anniversary of Hong Kong's return to the motherland and the inaugural ceremony of the sixth-term government of the Hong Kong Special Administrative Region.

Link: https://www.youtube.com/watch?v=xWiOKkXZM8s

SOURCE CCTV+


These press releases may also interest you

at 20:30
On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA"). Malignant glioma has...

at 20:10
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFN? in a...

at 20:00
NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of...

at 20:00
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major...

at 18:20
Biocom California, the association representing the life science industry of California, issued the following statement regarding the drug pricing portion in the Inflation Reduction Act. The statement can be attributed to Joe Panetta, Biocom...



News published on 2 july 2022 at 10:27 and distributed by: